Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease

被引：16

作者：

Kalkum, G. ^{[1
]}

Macchiella, D. ^{[2
]}

Reinke, J. ^{[1
]}

Koelbl, H. ^{[2
]}

Beck, M. ^{[1
]}

机构：

[1] Johannes Gutenberg Univ Mainz, Dept Lysosomal Storage Dis, Childrens Hosp, D-55131 Mainz, Germany

[2] Johannes Gutenberg Univ Mainz, Dept Obstet Gynaecol & Fetal Med, D-55131 Mainz, Germany

来源：

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2009年 / 144卷 / 01期

关键词：

D O I：

10.1016/j.ejogrb.2009.01.007

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

引用

页码：92 / 93

页数：2

共 5 条

[1]

Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study [J].

Baehner, F ;

Kampmann, C ;

Whybra, C ;

Miebach, E ;

Wiethoff, CM ;

Beck, M .

JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (07) :617-627

[2]

Fabry disease: overall effects of agalsidase alfa treatment [J].

Beck, M ;

Ricci, R ;

Widmer, U ;

Dehout, F ;

de Lorenzo, AG ;

Kampmann, C ;

Linhart, A ;

Sunder-Plassmann, G ;

Houge, G ;

Ramaswami, U ;

Gal, A ;

Mehta, A .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (12) :838-844

[3]

Dehout F, 2006, ACTA PAEDIATR, V95, P137

[4]

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa [J].

Wendt, S ;

Whybra, C ;

Kampmann, C ;

Teichmann, E ;

Beck, M .

JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 (05) :787-788

[5]

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy [J].

Whybra, C ;

Kampmann, C ;

Krummenauer, F ;

Ries, M ;

Mengel, E ;

Miebach, E ;

Baehner, F ;

Kim, K ;

Bajbouj, M ;

Schwarting, A ;

Gal, A ;

Beck, M .

CLINICAL GENETICS, 2004, 65 (04) :299-307

← 1 →